Publication

Article

Specialty Pharmacy Times

July/August 2013
Volume4
Issue 4

HCV and OBI Co-Infections May Increase Poor Outcomes

The results of a new study, published online on June 10, 2013, in the Journal of Hepatology, have found that chronic hepatitis C patients who are also infected with occult hepatitis B have a higher risk of progressing toward cirrhosis and of developing hepatocellular carcinoma.

Researchers of the observational study tested 326 chronic hepatitis C patients for occult hepatitis B virus infections (OBIs) through the analysis of liver biopsy DNA extracts from 1991 to 2000. Almost 40% of patients tested OBI positive and 94 of the original 326 were followed up for at least 5 years and for a maximum of 19 years. During the follow-up period, 79 patients received anti-hepatitis C virus treatments and 26 achieved a sustained virological response.

Approximately 35% of OBI-positive patients developed hepatocellular carcinoma, compared with just 9% of patients without OBI. Among patients who did not develop hepatocellular carcinoma, 33% of those with OBI developed advanced forms of cirrhosis, while only 13% of those infected with hepatitis C alone suffered cirrhosis. Of the 18 patients who died from liver-related causes during the follow-up period, 12 were OBI positive.

The researchers conclude that individuals infected with both hepatitis C and occult hepatitis B may have increased rated of cirrhosis and hepatocellular carcinoma and decreased rates of survival.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Cirrhosis illustration | Image credit: Rasi - stock.adobe.com
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs